For the Inventor, By the Inventor

Enter inventor name

Frankfurt am Main, Germany

Andreas Evers

USPTO Granted Patents = 32 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 24)

EPO Patents = 22 (Patent Applications = 37)

Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 82(Granted Patents)

Location History:

Florsheim, DE (2018)
Flörsheim, DE (2018)
Frankfurt-am-Main, DE (2013 - 2021)

Company Filing History:

31 out of 1,454

Antaros Medical Ab

Years Active: 2013-2021

Loading Chart...

Loading Chart...

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11141489 - Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid (2021-10-12),

2. 11046743 - Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes (2021-06-29),

3. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate (2020-10-20),

4. 10792367 - Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid (2020-10-06),

5. 10758592 - Exendin-4 derivatives as dual GLP1/glucagon agonists (2020-09-01),

6. 10583174 - FGF21 compound / GLP-1R agonist combinations with optimized activity ratio (2020-03-10),

7. 10538567 - Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists (2020-01-21),

8. 10519211 - Compounds as peptidic GLP1/glucagon/GIP receptor agonists (2019-12-31),

9. 10253079 - Functionalized Exendin-4 derivatives (2019-04-09),

10. 9982029 - Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists (2018-05-29),

11. 9932381 - Exendin-4 derivatives as selective glucagon receptor agonists (2018-04-03),

12. 9834527 - Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals (2017-12-05),

13. 9789165 - Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists (2017-10-17),

14. 9775904 - Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists (2017-10-03),

15. 9771406 - Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 (2017-09-26),

Title: The Innovative Mind of Andreas Evers

Introduction: Andreas Evers, a pioneering inventor hailing from Frankfurt am Main, Germany, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Andreas Evers has recently been granted patents for his cutting-edge inventions in the fields of renewable energy and sustainable transportation, showcasing his commitment to creating a greener future for generations to come.

Career Highlights: With a career spanning over two decades, Andreas Evers has established himself as a leading figure in the innovation landscape, with a focus on developing solutions that address pressing global challenges. His work has not only revolutionized industries but has also earned him recognition as a visionary inventor.

Collaborations: Throughout his career, Andreas Evers has collaborated with top research institutions, universities, and forward-thinking companies to bring his inventions to life. His ability to work across disciplines and sectors has led to the successful implementation of his groundbreaking ideas.

Conclusion: Andreas Evers' passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazing inventor in the world of technology. His contributions continue to inspire and shape the future of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…